Acute Myeloid Leukemia, in Relapsed or Refractory
2 clinical trials · Condition
◉ Watch Acute Myeloid Leukemia, in Relapsed or Refractory
| Record | Firm | Date |
|---|---|---|
| A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies (NCT06906380) | ARCE Therapeutics, Inc. | 2026-03-15 |
| Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy (NCT04541277) | Chinese PLA General Hospital | 2020-09-01 |
Track Acute Myeloid Leukemia, in Relapsed or Refractory automatically
Every clearance here is in the API, with alerts when new ones post.